Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Teva
Healthtrust
Julphar
Fish and Richardson
Baxter

Generated: May 26, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,030,095

« Back to Dashboard

Which drugs does patent 7,030,095 protect, and when does it expire?

Patent 7,030,095 protects NATROBA and is included in one NDA.

This patent has eleven patent family members in eleven countries.

Summary for Patent: 7,030,095
Title:Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs
Abstract:The present invention relates to composition and methods for administering compositions in solutions for killing adult lice and the ova comprising water, PVM/MA Decadiene crosspolymers, propylene glycol, a mixture of cetyl and stearyl alcohols, Ceteareth-20; stearalkonium chloride; benzyl alcohol; hexylene glycol; pentylene glycol, isopropyl alcohol; a mixture of spinosyn A and spinosyn D in a weight ratio of 80:20, BHT; and sodium hydroxide.
Inventor(s): Janssen; Herwig (Princeton, NJ), Ho; Kie (Princeton, NJ), Nystrand; Glenn (Lebanon, NJ), Williams; Dexter (Dayton, NJ), Lamb; C. Scott (Doylestown, PA)
Assignee: Johnson & Johnson Consumer Companies, Inc. (Skillman, NJ)
Application Number:10/230,460
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 7,030,095
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;

Drugs Protected by US Patent 7,030,095

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Parapro Llc NATROBA spinosad SUSPENSION;TOPICAL 022408-001 Jan 18, 2011 RX Yes Yes ➤ Sign Up ➤ Sign Up Y TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS FOUR (4) YEARS OF AGE AND OLDER ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 7,030,095

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 320713 ➤ Sign Up
Australia 3439702 ➤ Sign Up
Brazil 0201412 ➤ Sign Up
Canada 2382806 ➤ Sign Up
China 1382375 ➤ Sign Up
Germany 60210012 ➤ Sign Up
European Patent Office 1252820 ➤ Sign Up
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Daiichi Sankyo
Baxter
Argus Health
Queensland Health
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.